Over 10 years have passed since the first approval of a biologic agent for the treatment of
psoriasis. No one can argue that the arrival of this entirely new, highly effective class of …

Introduction: Photodynamic therapy for psoriasis showed promise in the early 1990s with
reports of plaque clearance following topical aminolevulinic acid–photodynamic therapy …

Over the years, many encouraging uncontrolled studies extolling treatments of SSc have
appeared, but initial impressions were not corroborated when controlled trials were done …

Background: Psoriasis is a disease with many manifestations for which numerous treatments
are available. Objective: The purpose of this article is to assess whether complete clearance …

Atopic dermatitis is a common skin disease characterized by severely pruritic eczematous
patches, papular and lichenified plaques, excoriations, cracks, and erosions. Photopheresis …

Morphea is a rare fibrosing skin disorder that occurs as a result of abnormal homogenized
collagen synthesis. Fractional ablative laser resurfacing has been used effectively in scar …

Localized scleroderma is a chronic inflammatory disease primarily of the dermis and
subcutaneous fat that ultimately leads to a scar-like sclerosis of connective tissue. The …

Photodynamic therapy refers to a new form of phototherapy in which non-psoralen
photosensitizing drugs are administered systemically or topically to an individual. The drugs …

Systemic sclerosis is an uncommon autoimmune connective tissue disease with multiorgan
system involvement and significant associated morbidity and mortality. Cutaneous signs and …

Photopheresis is a useful therapy for advanced cutaneous T-cell lymphoma, particularly for
Sezary syndrome. Additional conditions in which clinical studies have suggested a …